Greenwood Capital Associates’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
YIH
BS
MMA
BPC
FISPB
LSERS
Greenwood Capital Associates's TNDM Position: Q2 2026 in Review
Greenwood Capital Associates increased its Tandem Diabetes Care (TNDM) stake by 66% in Q2 2026, buying an estimated $160K and bringing the position to 23,078 shares worth $348K. The position accounts for 0.03% of the portfolio, ranked #255.
Greenwood Capital Associates first reported a position in TNDM in Q3 2019 and has held it in 15 quarters since. The position peaked at $1.16M in Q4 2021. 59 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.
- Greenwood Capital Associates held 23,078 shares of Tandem Diabetes Care worth $348K as of Q2 2026.
- Greenwood Capital Associates bought 9,137 Tandem Diabetes Care shares in Q2 2026, an estimated $160K.
- Tandem Diabetes Care made up 0.03% of Greenwood Capital Associates's portfolio in Q2 2026, its #255 holding.
- Greenwood Capital Associates first reported a position in Tandem Diabetes Care in Q3 2019 and has held it in 15 quarters since.
- Greenwood Capital Associates's Tandem Diabetes Care position peaked at $1.16M in Q4 2021.
- 59 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.
Based on Greenwood Capital Associates's 13F filing for Q2 2026, filed 28 Jul 2026.